<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>02317nam a22001697a 4500</leader>
  <controlfield tag="001">D0001J000635</controlfield>
  <controlfield tag="003">DOH</controlfield>
  <controlfield tag="005">20210514170020.0</controlfield>
  <controlfield tag="008">210514b           ||||| |||| 00| 0 eng d</controlfield>
  <datafield tag="245" ind1="0" ind2="0">
    <subfield code="a">Analysis of factors determining response to hepatitis B vaccination among hemodialysis patients /</subfield>
    <subfield code="c">Ma. Gina D. Villarama, AntonionB. Cayco</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
    <subfield code="a">Hepatitis B infection is a known complication among hemodialysis (HD) patients, because of their impaired cellular and humoral response and because of increased exposure to blood products. Hepatitis B vaccine is known to be effective in producing protection against hepatitis B virus in HD patients, however the antibody response or seroconversion is variable and very little information is available about the factors contributing to the reduced antibody response to Hepatitis B vaccination. This study attempts to determine the seroconversion rate and to identify factors associated with a positive response to hepatitis B vaccination among HD patients in Makati Medical Center.

A retrospective study was done among HD patients at the Kidney Unit of the Makati Medical Center from 1998 to 2002. A total of 32 patients qualified in the study Baseline and post-vaccination anti-HBs antibody tilers were monitored. Age, gender, dose, serum albumin, blood urea nitrogen (BUN), timing of vaccination, concomitant hepatitis C infection and diabetes mellitus (DM) were correlated and developed anti-HBs antibody titer.

Ten out of 32 patients seroconverted and developed anti-HBs liters post-vaccination, wilh seroconversion rate of 31.3 percent. Gender, dose, concomitant DM and Hepatitis C infection did not show any correlation with regards to anti-Hbs titer post vaccination. Age showed a trend lo correlate negatively with anti-Hbs tilers. Higher levels of BUN, albumin and longer interval between first dialysis and vaccination all trend lo correlate with higher anti-Hbs tiler. Test of significance of all parameters however failed lo meet p value &lt; 0.05. None of Ihe parameters proved predictive of negative or positive response to vaccination. (Author)</subfield>
  </datafield>
  <datafield tag="580" ind1=" " ind2=" ">
    <subfield code="a">
Makati Medical Center Proceedings, 2004 (18) pages  10-15</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="2">
    <subfield code="a">Hepatitis B Vaccines</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Villarama,  Ma. Gina D. </subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Cayco, AntonionB. </subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="c">JA</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">4664</subfield>
    <subfield code="d">4664</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="0">0</subfield>
    <subfield code="1">0</subfield>
    <subfield code="2">nlm</subfield>
    <subfield code="4">0</subfield>
    <subfield code="7">0</subfield>
    <subfield code="a">DOHCL</subfield>
    <subfield code="b">DOHCL</subfield>
    <subfield code="c">ElectronicRes</subfield>
    <subfield code="d">2021-05-14</subfield>
    <subfield code="l">0</subfield>
    <subfield code="o">J000635</subfield>
    <subfield code="p">D0001J000635</subfield>
    <subfield code="r">2021-05-14 00:00:00</subfield>
    <subfield code="w">2021-05-14</subfield>
    <subfield code="y">JA</subfield>
  </datafield>
</record>
